enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. ISTA Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Ista_Pharmaceuticals

   ISTA was acquired by Bausch & Lomb, an eye care company, on March 26, 2012. [2] Under the deal, Bausch & Lomb have agreed to pay $9.10 per share for ISTA, bringing the total value of the acquisition to $500 million. [3] In 2012, Valeant Pharmaceuticals withdrew its $360 million offer. [4]

3. Bausch & Lomb - Wikipedia

   en.wikipedia.org/wiki/Bausch_&_Lomb

   Bausch & Lomb (since 2010 stylized as Bausch + Lomb [2]) is an American-Canadian eye health products company based in Vaughan, Ontario, Canada. It is one of the world's largest suppliers of contact lenses , [ 3 ] lens care products, pharmaceuticals, intraocular lenses , and other eye surgery products.

4. Bausch Health - Wikipedia

   en.wikipedia.org/wiki/Bausch_Health

   Bausch Health owns Bausch & Lomb, a supplier of eye health products. Bausch Health's business model is primarily focused on acquiring small pharmaceutical companies and then sharply increasing the prices of the drugs these companies sell. [2] Valeant was originally founded in 1959, as ICN Pharmaceuticals by Milan Panić in California. During ...

5. Bausch Acquires License for Myopia Solution from Eyenovia

   www.aol.com/news/bausch-acquires-license-myopia...

   For premium support please call: 800-290-4726 more ways to reach us

6. ReNu - Wikipedia

   en.wikipedia.org/wiki/ReNu

   ReNu is a brand of soft contact lens care products produced by Bausch & Lomb. [1] By far the most popular brand of lens solutions until 2006, ReNu has rebranded its formulations as renu sensitive (formerly ReNu Multi-Purpose) and renu fresh (formerly ReNu MultiPlus), the latter containing a patented ingredient called hydranate, known by chemists as hydroxyalkylphosphonate, that removes protein ...

7. Bromfenac - Wikipedia

   en.wikipedia.org/wiki/Bromfenac

   Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) [2] marketed in the US as an ophthalmic solution (brand names Prolensa and Bromday, [3] prior formulation brand name Xibrom, which has since been discontinued) by ISTA Pharmaceuticals for short-term, local use. Prolensa and Bromday are the once-daily formulation of bromfenac, while ...